(R)-N,N-Dimethyl-1-[(S)-2-(diphenylphosphino)ferrocenyl]ethylamine
CAS : 55700-44-2
Ref. 3D-FD59972
1g | Arrêté | ||
50mg | Arrêté | ||
100mg | Arrêté | ||
250mg | Arrêté | ||
500mg | Arrêté |
Informations sur le produit
- (R)-(S)-PPFA
- (R)-(-)-N,N-Dimethyl-1-(2-diphenylphosphino)ferrocenylethylamine
- 1,2,3,4,5-cyclopentanepentayl, 1-[(1R)-1-(dimethylamino)ethyl]-2-(diphenylphosphino)-, compd. with 1,2,3,4,5-cyclopentanepentayl, iron salt (1:1:1)
(R)-N,N-Dimethyl-1-[(S)-2-(diphenylphosphino)ferrocenyl]ethylamine is a drug that has been shown to be effective in the treatment of different types of cancer. It is used as an inhibitor of the gene product HSP70, which is important for protein folding and function. The drug also has antioxidant properties and can help prevent certain types of cancers by inhibiting the formation of disulfide bonds. The drug has been shown to have clinical use in treating patients with chronic myelogenous leukemia and other hematologic malignancies. (R)-N,N-Dimethyl-1-[(S)-2-(diphenylphosphino)ferrocenyl]ethylamine inhibits cell proliferation by binding to the ferrous ion in cytochrome c oxidase, thereby preventing electron transport. This drug also shows optical properties that are sensitive to temperature changes and gas sensors that respond